These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1729634)

  • 1. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor.
    Giral P; Bruckert E
    N Engl J Med; 1992 Feb; 326(6):416-7. PubMed ID: 1729634
    [No Abstract]   [Full Text] [Related]  

  • 2. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor.
    Hanaki Y; Sugiyama S; Ozawa T; Ohno M
    N Engl J Med; 1991 Sep; 325(11):814-5. PubMed ID: 1870661
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.
    Cheng KH; Chu CS; Lin TH; Lee KT; Sheu SH; Lai WT
    Crit Care Med; 2015 Jun; 43(6):1255-64. PubMed ID: 25738856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.
    Drexel H; Amann FW; Beran J; Rentsch K; Candinas R; Muntwyler J; Luethy A; Gasser T; Follath F
    Circulation; 1994 Nov; 90(5):2230-5. PubMed ID: 7955178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease.
    Lavie CJ; Milani RV
    Am J Cardiol; 1994 Dec; 74(12):1192-5. PubMed ID: 7977088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
    Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
    Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.
    Hindy G; Engström G; Larsson SC; Traylor M; Markus HS; Melander O; Orho-Melander M;
    Stroke; 2018 Apr; 49(4):820-827. PubMed ID: 29535274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.